Neuroinflammation is becoming more center staged in Alzheimer’s. A research article published today in the Journal of Neuroscience demonstrated for the first time that neuroinflammation interrupts the neuronal connectivity in Alzheimer’s patients. The investigation led by Dr. Rowe at Medical Research Council, Cambridge UK, used brain imaging and biomarkers analysis. The study further proves the functional role of inflammation in the symptoms seen in Alzheimer’s patients.
The main ingredient used in Kondor Pharma’s lead product, Inflawell, has been shown to reduce inflammation in a clinical trial (Baram et al. 2019; and therefore may be useful for slowing down the process of memory loss associated with aging.